<- Go Home

Gilead Sciences, Inc.

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

Market Cap

$107.2B

Volume

6.7M

Cash and Equivalents

$2.8B

EBITDA

$13.5B

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$21.5B

Profit Margin

77.44%

52 Week High

$87.86

52 Week Low

$62.07

Dividend

3.58%

Price / Book Value

5.87

Price / Earnings

102.59

Price / Tangible Book Value

-8.34

Enterprise Value

$126.7B

Enterprise Value / EBITDA

9.30

Operating Income

$10.7B

Return on Equity

5.26%

Return on Assets

11.54

Cash and Short Term Investments

$3.8B

Debt

$23.4B

Equity

$18.2B

Revenue

$27.8B

Unlevered FCF

$7.4B

Sector

Biotechnology

Category

N/A

Company Stock Pitches